MYELODYSPLASTIC DISORDERS
Clinical trials for MYELODYSPLASTIC DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC DISORDERS trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer diagnosis revolution: new platform aims to personalize treatment
Diagnosis Recruiting nowThis study is testing a new platform that uses advanced genetic and functional tests to better understand tumors from 300 people with various high-risk cancers, including leukemia, myeloma, and pancreatic cancer. The goal is to see if this detailed analysis can change the recomme…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC
-
Blood cancer study aims to unlock disease secrets with High-Tech testing
Knowledge-focused Recruiting nowThis study is collecting blood, bone marrow, and tissue samples from over 1,000 people with blood cancers like leukemia and myeloma. Researchers will use advanced lab techniques to find unique markers (biomarkers) in each person's cancer. The goal is to better understand these di…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Scientists hunt for new drug targets in blood cancers
Knowledge-focused Recruiting nowThis study looks at blood cancer cells from 250 patients to understand which drugs might work best. Researchers will test many approved and experimental drugs on these cells in the lab. The goal is to find new treatment targets and match them to each patient's cancer type. This i…
Matched conditions: MYELODYSPLASTIC DISORDERS
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC